Tiffany Richards identifies the many recources she leverages to stay current on new treatments. Read More ›

Leslie Lauersdorf hopes that multiple myeloma can eventually become a chronic disease, if not cured completely, so that patients with the disease can live life uninterrupted. Read More ›

Leslie Lauersdorf is excited by the prospect of new mutliple myeloma therapies, and notes that finding the best sequence for each patient is key. Read More ›

Leslie Lauersdorf notes that having patients assist in managing their own side effects is important to help them stay on treatment and improve their quality of life. Read More ›

Leslie Lauersdorf believes patient education is important in both newly diagnosed pateints with multiple myeloma or patients with relapsed/refractory disease to help them understand their disease and the different treatment options. Read More ›

Beth Faiman discusses the difficulty of keeping abreast of all the new multiple myeloma treatments and how she personally stays up to date on all of the information. Read More ›

Leslie Lauersdorf discusses the need to balance optimism and realism in caring for patients with relapsed/refractory multiple myeloma. Read More ›

Leslie Lauersdorf addresses the challenges associated with staying abreast of the side effects, management, and sequencing for new multiple myeloma treatments. Read More ›

As patients with multiple myeloma are now living longer, survivorship care is becoming more crucial. Read More ›

Beth Faiman identifies how the Janssen CarePath program can financially help anyone who is diagnosed with multiple myeloma and requires daratumumab. Read More ›